PCM
TMDX icon

Polymer Capital Management’s Transmedics TMDX Stock Holding History

Polymer Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$290K Sell
2,916
-8,281
-74% -$1.08M 0.03% 626
2025
Q4 		$1.36M Buy
+11,197
New +$1.41M 0.14% 163

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Polymer Capital Management's TMDX Position: Q1 2026 in Review

Polymer Capital Management reduced its Transmedics (TMDX) stake by 74% in Q1 2026, selling an estimated $1.08M and leaving 2,916 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #626.

Polymer Capital Management first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Polymer Capital Management held 2,916 shares of Transmedics worth $290K as of Q1 2026.
  • Polymer Capital Management sold 8,281 Transmedics shares in Q1 2026, an estimated $1.08M.
  • Transmedics made up 0.03% of Polymer Capital Management's portfolio in Q1 2026, its #626 holding.
  • Polymer Capital Management first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
  • Polymer Capital Management's Transmedics position peaked at $1.36M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.